骨关节炎
医学
生药学
传统医学
生物
替代医学
生物活性
生物化学
病理
体外
作者
Jingyi Zhang,Lanbo Liu,Ziying Lao,Lei Li,Hui Xu,Xiwen Wang,Nan Lin,Peiyu Yan,Jiashun Yang,Ling Tang
标识
DOI:10.1016/j.jep.2025.119761
摘要
Our results demonstrated that HXP was an effective drug to improve the development of KOA. Among them, Salvianolic acid B, the most abundant compound in HXP and the best computer simulation result, may be the key monomer compound of HXP for KOA treatment. The results of the visualisation analysis further contributed to our understanding of HXP treatment of KOA in terms of changes in SHIP1, PTPRC proteins and cytochrome P450 enzyme family. This is associated with the SHIP1/PI3K/AKT and JAK2/STAT3 pathways, as well as arachidonic acid metabolism and immune regulation.
科研通智能强力驱动
Strongly Powered by AbleSci AI